Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02103842 · ClinicalTrials.gov registry record · Phase 1
Omega-3 Fatty Acids to Combat Sarcopenia
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT02103842: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT02103842 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02103842, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how omega-3 fatty acids influence muscle protein metabolism and mitochondrial physiology in the context of human aging.
Interventions
- DRUG Omega-3 fatty acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02103842
The ClinicalTrials.gov registry entry for NCT02103842 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omega-3 fatty acids is the first listed.
NCT02103842 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02103842 about?
NCT02103842 is a clinical study titled "Omega-3 Fatty Acids to Combat Sarcopenia". The purpose of this study is to determine how omega-3 fatty acids influence muscle protein metabolism and mitochondrial physiology in the context of human aging.
What is the current status of trial NCT02103842?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2014-03. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02103842?
The interventions under investigation include: Omega-3 fatty acids (DRUG).
Who is sponsoring clinical trial NCT02103842?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.